Paradis, Valerie

Publishing since 1993 (Senior)

Has published 113 publications in 18 years

Number of publications published per year by Paradis, Valerie. (Source : PubMed)

Distribution of publications types for Paradis, Valerie. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Ozenne V, Paradis V, Pernot S, Castelnau C, Vullierme MP, Bouattour M, Valla D, Farges O, Degos F. Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib.  Eur J Gastroenterol Hepatol  2010  
•  Vilgrain V, Paradis V. [Peripheric cholangiocarcinoma: radiopathologic correlations]  Gastroenterol. Clin. Biol.  2010;34;3  
•  Trawalé JM, Paradis V, Rautou PE, Francoz C, Escolano S, Sallée M, Durand F, Valla D, Lebrec D, Moreau R. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study.  Liver Int.  2009  
•  Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, Belghiti J. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas.  Gastroenterology  2009;137;5  
•  Lewin M, Vilgrain V, Ozenne V, Lemoine M, Wendum D, Paradis V, Ziol M, Arrivé L, Beaugrand M, Poupon R, Valla D, Chazouillères O, Corpechot C. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study.  Hepatology  2009;50;2  
•  Guedj N, Zhan Q, Perigny M, Rautou PE, Degos F, Belghiti J, Farges O, Bedossa P, Paradis V. Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas.  J. Hepatol.  2009;51;1  
•  Trak-Smayra V, Dargere D, Noun R, Albuquerque M, Yaghi C, Gannagé-Yared MH, Bedossa P, Paradis V. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.  Gut  2009;58;6  
•  Aussilhou B, Dokmak S, Faivre S, Paradis V, Vilgrain V, Belghiti J. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab.  Annals of surgical oncology  2009;16;6  
•  Malouf G, Dreyer C, Guedj N, Paradis V, Degos F, Belghiti J, Le Tourneau C, Faivre S, Raymond E. [Prognosis factors of cholangiocarcinoma: contribution of recent molecular biology tools]  Bulletin du cancer  2009;96;4  
•  Paradis V, Zalinski S, Chelbi E, Guedj N, Degos F, Vilgrain V, Bedossa P, Belghiti J. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.  Hepatology  2009;49;3  

[ See timeline ] [ See all publications ]